113 related articles for article (PubMed ID: 3106054)
21. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
22. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
[TBL] [Abstract][Full Text] [Related]
23. Procollagen type III aminoterminal peptide in serum in idiopathic myelofibrosis and allied conditions: relation to disease activity and effect of chemotherapy.
Hasselbalch H; Junker P; Hørslev-Petersen K; Lisse I; Bentsen KD
Am J Hematol; 1990 Jan; 33(1):18-26. PubMed ID: 2293759
[TBL] [Abstract][Full Text] [Related]
24. Markers of type I and type III collagen synthesis in serum as indicators of tissue growth during pregnancy.
Puistola U; Risteli L; Kauppila A; Knip M; Risteli J
J Clin Endocrinol Metab; 1993 Jul; 77(1):178-82. PubMed ID: 8325940
[TBL] [Abstract][Full Text] [Related]
25. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
Koivula MK; Risteli L; Risteli J
Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
[TBL] [Abstract][Full Text] [Related]
26. Aminoterminal propeptide of type III procollagen in serum during wound healing in human beings.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Surgery; 1990 Apr; 107(4):381-8. PubMed ID: 2321135
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of carboxyterminal propeptide of type I procollagen, aminoterminal propeptide of type III procollagen and laminin P1 in Duchenne muscular dystrophy.
von Moers A; Danne T; Möller P; Scheffner D
Acta Paediatr; 1997 Apr; 86(4):377-80. PubMed ID: 9174223
[TBL] [Abstract][Full Text] [Related]
28. [High risk pregnancies. Prognostic value and plasma levels of human chorionic somatomammotropin].
Cohen M; Dumont M; Bertrand J
J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):697-713. PubMed ID: 4196593
[No Abstract] [Full Text] [Related]
29. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
30. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor beta in hypertensives with cardiorenal damage.
Laviades C; Varo N; Díez J
Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
[TBL] [Abstract][Full Text] [Related]
32. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
[TBL] [Abstract][Full Text] [Related]
33. Effect of gynecological operations on the serum concentration of the aminoterminal propeptide of type III procollagen.
Tomás C; Puistola U; Risteli L; Risteli J; Kauppila A
Acta Obstet Gynecol Scand; 1993 Jul; 72(5):391-5. PubMed ID: 8392273
[TBL] [Abstract][Full Text] [Related]
34. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
35. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
36. Serum concentrations of the N-terminal propeptide of type III procollagen and two type IV collagen fragments and gene expression of the respective collagen types in liver in rats with dimethylnitrosamine-induced hepatic fibrosis.
Savolainen ER; Brocks D; Ala-Kokko L; Kivirikko KI
Biochem J; 1988 Feb; 249(3):753-7. PubMed ID: 3355495
[TBL] [Abstract][Full Text] [Related]
37. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
38. Radioimmunoassay for estrogens in maternal blood in late pregnancy: values for normal and complicated pregnancy.
Podoba V; Rizkallah TH; Kelly WG
Am J Obstet Gynecol; 1973 Oct; 117(3):321-30. PubMed ID: 4125771
[No Abstract] [Full Text] [Related]
39. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
40. [The significance of radioimmunological HPL determination in obstetrics (author's transl)].
Scholz K; Gant H; Ladurner D; Geir W
Wien Klin Wochenschr; 1975 Sep; 87(16):515-21. PubMed ID: 818820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]